Cargando…

Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support

A formal assessment of pharmacogenomics clinical decision support (PGx-CDS) by providers is lacking in the literature. The objective of this study was to evaluate the usability of PGx-CDS tools that have been implemented in a healthcare setting. We enrolled ten prescribing healthcare providers and h...

Descripción completa

Detalles Bibliográficos
Autores principales: Elchynski, Amanda L., Desai, Nina, D’Silva, Danielle, Hall, Bradley, Marks, Yael, Wiisanen, Kristin, Cicali, Emily J., Cavallari, Larisa H., Nguyen, Khoa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618963/
https://www.ncbi.nlm.nih.gov/pubmed/34834578
http://dx.doi.org/10.3390/jpm11111227
_version_ 1784604874887921664
author Elchynski, Amanda L.
Desai, Nina
D’Silva, Danielle
Hall, Bradley
Marks, Yael
Wiisanen, Kristin
Cicali, Emily J.
Cavallari, Larisa H.
Nguyen, Khoa A.
author_facet Elchynski, Amanda L.
Desai, Nina
D’Silva, Danielle
Hall, Bradley
Marks, Yael
Wiisanen, Kristin
Cicali, Emily J.
Cavallari, Larisa H.
Nguyen, Khoa A.
author_sort Elchynski, Amanda L.
collection PubMed
description A formal assessment of pharmacogenomics clinical decision support (PGx-CDS) by providers is lacking in the literature. The objective of this study was to evaluate the usability of PGx-CDS tools that have been implemented in a healthcare setting. We enrolled ten prescribing healthcare providers and had them complete a 60-min usability session, which included interacting with two PGx-CDS scenarios using the “Think Aloud” technique, as well as completing the Computer System Usability Questionnaire (CSUQ). Providers reported positive comments, negative comments, and suggestions for the two PGx-CDS during the usability testing. Most provider comments were in favor of the current PGx-CDS design, with the exception of how the genotype and phenotype information is displayed. The mean CSUQ score for the PGx-CDS overall satisfaction was 6.3 ± 0.95, with seven strongly agreeing and one strongly disagreeing for overall satisfaction. The implemented PGx-CDS at our institution was well received by prescribing healthcare providers. The feedback collected from the session will guide future PGx-CDS designs for our healthcare system and provide a framework for other institutions implementing PGx-CDS.
format Online
Article
Text
id pubmed-8618963
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86189632021-11-27 Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support Elchynski, Amanda L. Desai, Nina D’Silva, Danielle Hall, Bradley Marks, Yael Wiisanen, Kristin Cicali, Emily J. Cavallari, Larisa H. Nguyen, Khoa A. J Pers Med Article A formal assessment of pharmacogenomics clinical decision support (PGx-CDS) by providers is lacking in the literature. The objective of this study was to evaluate the usability of PGx-CDS tools that have been implemented in a healthcare setting. We enrolled ten prescribing healthcare providers and had them complete a 60-min usability session, which included interacting with two PGx-CDS scenarios using the “Think Aloud” technique, as well as completing the Computer System Usability Questionnaire (CSUQ). Providers reported positive comments, negative comments, and suggestions for the two PGx-CDS during the usability testing. Most provider comments were in favor of the current PGx-CDS design, with the exception of how the genotype and phenotype information is displayed. The mean CSUQ score for the PGx-CDS overall satisfaction was 6.3 ± 0.95, with seven strongly agreeing and one strongly disagreeing for overall satisfaction. The implemented PGx-CDS at our institution was well received by prescribing healthcare providers. The feedback collected from the session will guide future PGx-CDS designs for our healthcare system and provide a framework for other institutions implementing PGx-CDS. MDPI 2021-11-18 /pmc/articles/PMC8618963/ /pubmed/34834578 http://dx.doi.org/10.3390/jpm11111227 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Elchynski, Amanda L.
Desai, Nina
D’Silva, Danielle
Hall, Bradley
Marks, Yael
Wiisanen, Kristin
Cicali, Emily J.
Cavallari, Larisa H.
Nguyen, Khoa A.
Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
title Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
title_full Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
title_fullStr Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
title_full_unstemmed Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
title_short Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
title_sort utilizing a human–computer interaction approach to evaluate the design of current pharmacogenomics clinical decision support
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618963/
https://www.ncbi.nlm.nih.gov/pubmed/34834578
http://dx.doi.org/10.3390/jpm11111227
work_keys_str_mv AT elchynskiamandal utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport
AT desainina utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport
AT dsilvadanielle utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport
AT hallbradley utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport
AT marksyael utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport
AT wiisanenkristin utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport
AT cicaliemilyj utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport
AT cavallarilarisah utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport
AT nguyenkhoaa utilizingahumancomputerinteractionapproachtoevaluatethedesignofcurrentpharmacogenomicsclinicaldecisionsupport